financing

News

Latigo has tapped into investor interest in pain relief medicines with new, non-opioid mechanisms of action, raising $150 million in a Series B.

News

Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery operations.

News

Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances.

News

Sofinnova has raised €1.2bn that it says could support 50 to 60 companies across biotech, medtech, industrial biotech, and digital medicine.

News

Eikon has added to its already copious cash reserves with a $351m round for its expanding pipeline of cancer therapies.

News

Abcuro has raised $200m in financing that should allow it to complete a pivotal trial of ulviprubart for rare disease inclusion body myositis (IBM).